Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation. Evidence-based clinical science should guide FDA decision making about product labeling

Lee P. Shulman, Louise H. Bateman, Mitchell D Creinin, Vanessa E. Cullins, Lee Lee Doyle, Emily Godfrey, Patricia Murphy, Pablo Rodriguez, Scott J. Spear, Felicia H. Stewart, Michael A. Thomas, Carolyn L. Westhoff, Sandra Worthington

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)440-442
Number of pages3
Issue number5
StatePublished - May 2006
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this